Open AccessBioequivalence assessment of the two brands of glimepiride tablets
Author(s) -
Dušan Jovanović,
D. Stojsic,
Milica Zlatković,
Jasmina Jović-Stošić,
Miodrag Jovanović
Publication year - 2006
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0612015j
Subject(s) - glimepiride , bioequivalence , medicine , pharmacology , traditional medicine , pharmacokinetics , metformin , insulin
Glimepiride, as an antidiabetic from the group of sulfonylurea, is administered perorally in the treatment of diabetes mellitus. The aim of this study was to compare pharmacokinetic profiles and relative bioavailabilities of the two oral formulations of glimepiride, generic and innovator tablets, after a single dose of the active drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom